These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35453934)

  • 1. Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2.
    Díaz-Troyano N; Gabriel-Medina P; Weber S; Klammer M; Barquín-DelPino R; Castillo-Ribelles L; Esteban A; Hernández-González M; Ferrer-Costa R; Pumarola T; Rodríguez-Frías F
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2.
    Mariappan V; Ranganadin P; Shanmugam L; Rao SR; Balakrishna Pillai A
    Biochimie; 2022 Oct; 201():139-147. PubMed ID: 35724946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.
    Lundström A; Ziegler L; Havervall S; Rudberg AS; von Meijenfeldt F; Lisman T; Mackman N; Sandén P; Thålin C
    J Med Virol; 2021 Oct; 93(10):5908-5916. PubMed ID: 34138483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Wallentin L; Lindbäck J; Eriksson N; Hijazi Z; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Oldgren J; Siegbahn A
    Eur Heart J; 2020 Nov; 41(41):4037-4046. PubMed ID: 32984892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
    Rahman MM; Hasan M; Ahmed A
    Rev Med Virol; 2021 Sep; 31(5):1-12. PubMed ID: 33426683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment.
    Daniell H; Nair SK; Shi Y; Wang P; Montone KT; Shaw PA; Choi GH; Ghani D; Weaver J; Rader DJ; Margulies KB; Collman RG; Laudanski K; Bar KJ
    Mol Ther Methods Clin Dev; 2022 Sep; 26():266-278. PubMed ID: 35818571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in circulating soluble form of ACE2 protein in moderate and severe COVID-19 and healthy controls.
    Robertson J; Nellgård B; Hultén LM; Nilsson S; Dalla K; Börjesson M; Zetterberg H; Svanvik J; Gisslén M
    Front Med (Lausanne); 2022; 9():1058120. PubMed ID: 36569121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between soluble angiotensin-converting enzyme 2 in saliva and SARS-CoV-2 infection: a cross-sectional study.
    Bru S; Brotons P; Jordan I; Alsina L; Henares D; Carballar R; de Sevilla MF; Barrabeig I; Fumado V; Baro B; Martínez-Láinez JM; Garcia-Garcia JJ; Bassat Q; Balaguer A; Clotet J; Launes C; Muñoz-Almagro C
    Sci Rep; 2023 Apr; 13(1):5985. PubMed ID: 37045853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS-CoV-2 infection.
    Kim HK; Cho J; Kim E; Kim J; Yang JS; Kim KC; Lee JY; Shin Y; Palomera LF; Park J; Baek SH; Bae HG; Cho Y; Han J; Sul JH; Lee J; Park JH; Cho YW; Lee W; Jo DG
    J Extracell Vesicles; 2022 Jan; 11(1):e12179. PubMed ID: 34982509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of Soluble Angiotensin Converting Enzyme 2 (sACE2) in Children and Adults with and without COVID-19.
    Wissing SI; Obeid R; Rädle-Hurst T; Rohrer T; Herr C; Schöpe J; Geisel J; Bals R; Abdul-Khaliq H
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection.
    Feng F; Chen J; Zhao J; Li Y; Li M; Sun C
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2.
    C SK; Kumar SA; Wei H
    Toxicol Rep; 2020; 7():1366-1372. PubMed ID: 33052306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of soluble angiotensin-converting enzyme 2 concentrations in adult patients with complex congenital heart disease.
    Raedle-Hurst T; Wissing S; Mackenstein N; Obeid R; Geisel J; Wagenpfeil S; Abdul-Khaliq H
    Clin Res Cardiol; 2022 Feb; 111(2):154-162. PubMed ID: 33280062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE2 Shedding and the Role in COVID-19.
    Wang J; Zhao H; An Y
    Front Cell Infect Microbiol; 2021; 11():789180. PubMed ID: 35096642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system.
    Yeung ML; Teng JLL; Jia L; Zhang C; Huang C; Cai JP; Zhou R; Chan KH; Zhao H; Zhu L; Siu KL; Fung SY; Yung S; Chan TM; To KK; Chan JF; Cai Z; Lau SKP; Chen Z; Jin DY; Woo PCY; Yuen KY
    Cell; 2021 Apr; 184(8):2212-2228.e12. PubMed ID: 33713620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo.
    Kayabolen A; Akcan U; Özturan D; Ulbegi-Polat H; Sahin GN; Pinarbasi-Degirmenci N; Bayraktar C; Soyler G; Sarayloo E; Nurtop E; Ozer B; Guney-Esken G; Barlas T; Yildirim IS; Dogan O; Karahuseyinoglu S; Lack NA; Kaya M; Albayrak C; Can F; Solaroglu I; Bagci-Onder T
    Adv Sci (Weinh); 2022 Sep; 9(27):e2201294. PubMed ID: 35896894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
    Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
    Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity.
    Akin S; Schriek P; van Nieuwkoop C; Neuman RI; Meynaar I; van Helden EJ; Bouazzaoui HE; Baak R; Veuger M; Mairuhu RATA; van den Berg L; van Driel V; Visser LE; de Jonge E; Garrelds IM; Duynstee JFAB; van Rooden JK; Ludikhuize J; Verdonk K; Caliskan K; Jansen T; van Schaik RHN; Danser AHJ
    J Hypertens; 2022 Mar; 40(3):606-614. PubMed ID: 34862332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble ACE2 as a potential therapy for COVID-19.
    Krishnamurthy S; Lockey RF; Kolliputi N
    Am J Physiol Cell Physiol; 2021 Mar; 320(3):C279-C281. PubMed ID: 33502950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.